Intravenous Thrombolytic Therapy in Acute Ischemic Stroke: The Experience of Kutahya

Creative Commons License

ÇETİNER M., Kabay S. C., AYDIN H. E.

TURKISH JOURNAL OF NEUROLOGY, vol.23, no.4, pp.193-198, 2017 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.4274/tnd.35651
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.193-198
  • Kütahya Health Sciences University Affiliated: No


Objective: Stroke is a serious cause of mortality and disability. The caregiver of the patients may be adversely affected by this situation as well. In addition, stroke has a great economic burden on healthcare. Significant improvement has been achieved in the field of diagnosis, treatment, and care in the acute phase of the ischemic stroke in recent years. Thrombolysis with intravenous (IV) recombinant tissue type plasminogen activator (r-tPA) is the main treatment option in selected patients. The aim of our study was to share the results of intravenous (IV) thrombolytic therapy applied to patients with acute ischemic stroke in our clinic.